Stephen Denaro Resigns from Anteris Board
TipRanks (Mon, 15-Dec 6:29 AM ET)
Anteris Technologies Presents Data from 100 DurAVR THV Patients at PCR London Valves
Globe Newswire (Mon, 17-Nov 6:00 AM ET)
Anteris Announces Results for the Third Quarter of 2025
Globe Newswire (Wed, 12-Nov 5:52 PM ET)
FDA Approves Anteris's DurAVR THV Global Pivotal Trial (the "PARADIGM Trial")
Globe Newswire (Mon, 3-Nov 7:00 AM ET)
Globe Newswire (Tue, 28-Oct 6:08 PM ET)
Market Chameleon (Tue, 28-Oct 3:46 AM ET)
Globe Newswire (Mon, 27-Oct 5:43 PM ET)
Anteris Technologies Announces One-Year Clinical Outcomes for DurAVR THV to be Presented at TCT 2025
Globe Newswire (Mon, 27-Oct 8:43 AM ET)
Globe Newswire (Wed, 15-Oct 9:18 AM ET)
Anteris Technologies Global Corp. Announces Adjournment of Special Meeting of Stockholders
Globe Newswire (Fri, 19-Sep 2:30 AM ET)
Anteris Technologies Global Corp is a structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function. Its product, the DurAVR Transcatheter Heart Valve (THV), was designed in partnership with the world's interventional cardiologists and cardiac surgeons to treat aortic stenosis a potentially life-threatening condition resulting from the narrowing of the aortic valve. The balloon-expandable DurAVR THV is the first biomimetic valve, which is shaped to mimic the performance of a healthy human aortic valve and aims to replicate normal aortic blood flow. Company operates in USA, Germany, Australia, Switzerland, and Sweden. Majority of revenue is from USA.
Anteris Technologies Glb trades on the NASDAQ stock market under the symbol AVR.
As of December 12, 2025, AVR stock price declined to $4.98 with 167,397 million shares trading.
AVR has a beta of 1.77, meaning it tends to be more sensitive to market movements. AVR has a correlation of 0.09 to the broad based SPY ETF.
AVR has a market cap of $205.16 million. This is considered a Small Cap stock.
Last quarter Anteris Technologies Glb reported $429,000 in Revenue and -$.62 earnings per share. This fell short of revenue expectation by $-306,500 and missed earnings estimates by -$.05.
The top ETF exchange traded funds that AVR belongs to (by Net Assets): IWM, VXF, IWO, VTWO, IWC.
AVR support price is $4.95 and resistance is $5.55 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AVR shares will trade within this expected range on the day.
